Skip to main content

CASE REPORT article

Front. Cardiovasc. Med.
Sec. Cardiovascular Biologics and Regenerative Medicine
Volume 11 - 2024 | doi: 10.3389/fcvm.2024.1401566

C-reactive protein apheresis in non-ST-elevation ACS (NSTE-ACS) -case series from the C-reactive protein apheresis in Acute Myocardial Infarction-Registry (CAMI-R)

Provisionally accepted
Jan Torzewski Jan Torzewski 1*Stephan Mattecka Stephan Mattecka 2Fabrizio Esposito Fabrizio Esposito 3Franz Dr. Heigl Franz Dr. Heigl 4Jacqueline Fiedler Jacqueline Fiedler 1Ahmed Sheriff Ahmed Sheriff 2
  • 1 Kempten Clinic, Kempten, Germany
  • 2 Pentracor GmbH, Hennigsdorf, Germany
  • 3 Gemeinschaftskrankenhaus Havelhöhe, Berlin, Baden-Württemberg, Germany
  • 4 F Heigl, Kempten, Germany

The final, formatted version of the article will be published soon.

    C-reactive protein (CRP) apheresis has been introduced in ST-elevation myocardial infarction and cardiogenic shock. Here, we describe first-in-man application in non-ST-elevation ACS (NSTE-ACS). Seven NSTE-ACS patients with high CRP levels (14.2 mg/L - 154 mg/L) were treated with CRP apheresis. Treatment was well-tolerated. Patients were discharged in good clinical condition.

    Keywords: C-reactive protein apheresis, non-ST-elevation ACS, acute coronary syndrome C-reactive protein (CRP), ST-elevation myocardial infarction (STEMI), Cardiogenic shock (CS), non-ST-elevation acute coronary syndrome (NSTE-ACS), Chest Pain Unit (CPU), Randomized controlled trial (RCT), Onset of Symptoms (OoS)

    Received: 15 Mar 2024; Accepted: 25 Jul 2024.

    Copyright: © 2024 Torzewski, Mattecka, Esposito, Dr. Heigl, Fiedler and Sheriff. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Jan Torzewski, Kempten Clinic, Kempten, Germany

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.